Cationic Microvesicles with Neutral Polymer Stabilization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The existing methods for preparing calibrated gas-filled microvesicles using flow-focusing microfluidic techniques fail to effectively incorporate cationic lipids due to the presence of negatively charged pegylated phospholipids, resulting in insufficient overall positive charge on the microvesicles.
Innovation Solution
A suspension of gas-filled microvesicles with a stabilizing envelope comprising a cationic lipid and a neutral or cationic amphiphilic polymeric compound, where the polymeric compound is present in a molar amount higher than 3%, and the microvesicles have a geometric standard deviation (GSD) value of at least 1.25 or lower.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Stability of the object's composition
If negatively charged pegylated phospholipids are used to stabilize the microvesicle envelope, then the stabilizing layer is formed and coalescence is limited, but the incorporation of cationic lipids is substantially reduced or prevented, resulting in insufficient overall positive charge
Solution Approach 1:
The patent removes the negatively charged pegylated phospholipid component from the formulation to eliminate its harmful electrostatic repulsion effect on cationic lipid incorporation, while retaining the stabilizing function through alternative neutral or cationic amphiphilic compounds
Solution Approach 2:
The patent converts the harmful electrostatic repulsion caused by negatively charged pegylated phospholipids into a beneficial formulation strategy by deliberately selecting neutral or cationic amphiphilic compounds that electrostatically attract and facilitate cationic lipid incorporation into the microvesicle envelope
2Manufacturing precision
If flow-focusing microfluidic techniques are used to prepare calibrated microvesicles, then narrow size distribution is achieved, but effective incorporation of cationic lipids is prevented due to presence of negatively charged pegylated phospholipids
Solution Approach 1:
The patent changes the electrostatic parameter of the amphiphilic compound formulation from negative to neutral or positive charge, which fundamentally alters the interaction mechanism with cationic lipids during the flow-focusing microfluidic process, enabling effective incorporation while maintaining calibrated size distribution
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The described solution achieves an overall positive charge on the microvesicles, enabling effective binding of negatively charged genetic material and enhancing the efficiency of ultrasound-mediated therapeutic treatments.
Implementation Method 1
a stabilizing envelope comprising an amphiphilic material, wherein said amphiphilic material comprises a cationic lipid and a neutral or cationic amphiphilic polymeric compound
Implementation Method 2
said amphiphilic material comprises a cationic lipid... achieving an overall positive charge on the microvesicles, enabling effective binding of negatively charged genetic material
Implementation Method 3
the flow-focusing technology allows the manufacturing of calibrated microvesicles... with a geometric standard deviation (GSD) value of at least 1.25 or lower
Data Source
AI summary
Technical field The invention relates to new calibrated-size gas-filled microvesicles bearing an overall positive charge, to their use and to their method of manufacturing. The gas-filled microvesicles have a geometric standard deviation (GSD) value of at least 1.25 or lower and a stabilizing envelope comprising an amphiphilic material, said amphiphilic material comprising a cationic lipid and a neutral or cationic amphiphilic polymeric compound.


